Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.
Compare To Other CompaniesAll Reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount (USD)
| Value | Reported On | Form | FY | FP | Start Date | End Date | Fiscal Period |
|---|---|---|---|---|---|---|---|
| $2,900,000.00 | 2023-05-03 | 10-Q | 2023 | Q1 | 2023-03-31 | CY2023Q1I | |
| $4,700,000.00 | 2023-08-03 | 10-Q | 2023 | Q2 | 2023-06-30 | ||
| $4,700,000.00 | 2024-02-26 | 10-K | 2023 | FY | 2023-06-30 | ||
| $4,700,000.00 | 2024-05-06 | 10-Q | 2024 | Q1 | 2023-06-30 | CY2023Q2I | |
| $4,700,000.00 | 2023-11-02 | 10-Q | 2023 | Q3 | 2023-09-30 | CY2023Q3I |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Aggregated Data
SEC filing data for all companies grouped by time and accounting terms
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations